RAMSAY HEALTH CARE LIMITED (RHC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RHC - RAMSAY HEALTH CARE LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Founded in Sydney in 1964, Ramsay Health Care is the largest provider of private healthcare in Australia, with operations in the UK, France, Indonesia and Malaysia. The company specialises in surgery, rehabilitation and psychiatric care. It was first listed in 1997.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$66.04

05 Dec
2022

-0.110

OPEN

$66.00

-0.17%

HIGH

$66.32

467,688

LOW

$65.21

TARGET
$67.16 1.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . SHL . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
RHC: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx 116.3 180.0 xxx
DPS (cps) xxx 97.0 111.0 xxx
EPS Growth xxx - 39.8% 54.7% xxx
DPS Growth xxx - 36.0% 14.4% xxx
PE Ratio xxx N/A 36.7 xxx
Dividend Yield xxx N/A 1.7% xxx
Div Pay Ratio(%) xxx 83.4% 61.7% xxx

Dividend yield today if purchased 3 years ago: 1.36%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.47

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 05/09 - ex-div 48.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx116.3
DPS All xxxxxxxxxxxxxxx97.0
Sales/Revenue xxxxxxxxxxxxxxx13,175.8 M
Book Value Per Share xxxxxxxxxxxxxxx1,616.0
Net Operating Cash Flow xxxxxxxxxxxxxxx719.9 M
Net Profit Margin xxxxxxxxxxxxxxx2.08 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx7.10 %
Return on Invested Capital xxxxxxxxxxxxxxx1.93 %
Return on Assets xxxxxxxxxxxxxxx1.41 %
Return on Equity xxxxxxxxxxxxxxx6.88 %
Return on Total Capital xxxxxxxxxxxxxxx2.13 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-340.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

14/11/2022

3

Downgrade to Neutral from Buy

$62.00

-6.12%

Ramsay Health Care's latest trading update has given Citi increased confidence that post-covid recovery is underway in Australia. Despite this, Citi flags that performance in Europe and the UK remains challenged. 

The broker highlights labour shortages had a significant impact on first quarter performance in the UK. While the company guided to a gradual recovery through FY23, ahead of more normalised conditions in FY24, Citi lowered earnings per share forecasts -15%, -5% and -2% through to FY25 on a weaker quarter. 

The rating is downgraded to Neutral from Buy and the target price decreases to $62.00 from $73.00.

FORECAST
Citi forecasts a full year FY23 dividend of 110.00 cents and EPS of 186.10 cents.
Citi forecasts a full year FY24 dividend of 178.00 cents and EPS of 273.60 cents.

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxxxxxx xx xxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

RHC STOCK CHART